| 2024 |
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies |
Articolo in rivista |
Vai |
| 2024 |
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies |
Review essay (rassegna critica) |
Vai |
| 2024 |
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review. |
Review essay (rassegna critica) |
Vai |
| 2024 |
Impact of different hormones on the regulation of nitric oxide in diabetes |
Articolo in rivista |
Vai |
| 2023 |
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update |
Review essay (rassegna critica) |
Vai |
| 2023 |
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? |
Review essay (rassegna critica) |
Vai |
| 2023 |
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes |
Articolo in rivista |
Vai |
| 2023 |
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance |
Articolo in rivista |
Vai |
| 2023 |
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study |
Articolo in rivista |
Vai |
| 2022 |
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes |
Review essay (rassegna critica) |
Vai |
| 2022 |
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study |
Articolo in rivista |
Vai |
| 2022 |
Obesity and HFpEF |
Nota o commento |
Vai |
| 2022 |
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes |
Articolo in rivista |
Vai |
| 2021 |
Novel therapeutical approaches to managing atherosclerotic risk |
Review essay (rassegna critica) |
Vai |
| 2021 |
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus |
Review essay (rassegna critica) |
Vai |
| 2021 |
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome |
Review essay (rassegna critica) |
Vai |
| 2021 |
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect |
Articolo in rivista |
Vai |
| 2020 |
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect |
Articolo in rivista |
Vai |
| 2020 |
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study |
Articolo in rivista |
Vai |
| 2020 |
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes |
Articolo in rivista |
Vai |
| 2020 |
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study |
Articolo in rivista |
Vai |
| 2020 |
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes |
Review essay (rassegna critica) |
Vai |
| 2019 |
Future perspectives of the pharmacological management of diabetic dyslipidemia |
Review essay (rassegna critica) |
Vai |
| 2019 |
Advances in pharmacological treatment of type 1 diabetes during pregnancy |
Review essay (rassegna critica) |
Vai |
| 2019 |
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study |
Articolo in rivista |
Vai |
| 2019 |
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study |
Articolo in rivista |
Vai |
| 2018 |
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases |
Articolo in rivista |
Vai |
| 2018 |
Pharmacotherapy for gestational diabetes |
Articolo in rivista |
Vai |
| 2018 |
Metabolic disorders during pregnancy and postpartum cardiometabolic risk |
Articolo in rivista |
Vai |
| 2018 |
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms |
Articolo in rivista |
Vai |
| 2018 |
Natural approaches in metabolic syndrome management |
Review essay (rassegna critica) |
Vai |
| 2018 |
Management of Statin Intolerance in 2018: Still More Questions Than Answers |
Articolo in rivista |
Vai |
| 2018 |
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? |
Articolo in rivista |
Vai |
| 2018 |
PREVALENCE OF LIVER STEATOSIS AND FIBROSIS AND RELIABILITY OF ULTRASOUND IN DETECTING NAFLD IN OBESE PATIENTS |
Poster pubblicato in volume |
Vai |
| 2018 |
The Role of Nutraceuticals in Statin Intolerant Patients |
Articolo in rivista |
Vai |
| 2017 |
Nutraceuticals as an important part of combination therapy in dyslipidaemia |
Review essay (rassegna critica) |
Vai |
| 2016 |
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici |
Articolo in rivista |
Vai |
| 2016 |
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study |
Articolo in rivista |
Vai |
| 2016 |
The effect of bergamot on dyslipidemia |
Articolo in rivista |
Vai |
| 2016 |
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study |
Articolo in rivista |
Vai |
| 2015 |
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome |
Articolo in rivista |
Vai |
| 2015 |
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan |
Articolo in rivista |
Vai |
| 2015 |
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study |
Articolo in rivista |
Vai |
| 2014 |
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study |
Proceedings |
Vai |
| 2014 |
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. |
Articolo in rivista |
Vai |
| 2014 |
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study |
Articolo in rivista |
Vai |
| 2014 |
PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD) |
Articolo in rivista |
Vai |
| 2014 |
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study |
Altro |
Vai |
| 2014 |
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis |
Articolo in rivista |
Vai |
| 2014 |
Effects of Liraglutide on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with The Metabolic Syndrome: A 12-Month Prospective Pilot Study |
Altro |
Vai |
| 2013 |
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease |
Proceedings |
Vai |
| 2013 |
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. |
Articolo in rivista |
Vai |
| 2013 |
Smoking and small, dense low-density lipoproteins. |
Recensione in rivista |
Vai |
| 2013 |
INCRETIN-BASED THERAPIES, GLUCOMETABOLIC HEALTH AND ENDOVASCULAR INFLAMMATION |
Articolo in rivista |
Vai |
| 2013 |
Serological, immunomorphological and bioinformatics analyses suggest Hsp60 is involved in Hashimoto’s thyroiditis pathogenesis. |
Proceedings |
Vai |
| 2013 |
Anti-atherogenic Effects of 17β-Estradiol |
Articolo in rivista |
Vai |
| 2012 |
MALIGNANT TUMOR-LIKE GAASTRIC LESION DUE TO CANDIDA ALBICANS IN A DIABETIC PATIENT TREATED WITH CYCLOSPORIN: A CASE REPORT AND REVIEW OF THE LITERATURE |
Articolo in rivista |
Vai |
| 2012 |
Autoimmune liver disease in a sicilian woman. |
Articolo in rivista |
Vai |
| 2012 |
Oxidative stress and small, dense low-density lipoproteins: Current and future perspectives |
Articolo in rivista |
Vai |
| 2012 |
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. |
Abstract in rivista |
Vai |
| 2012 |
Lichen sclerosus as a cause of recurrent cystitis: case report and review of the literatury. |
Articolo in rivista |
Vai |
| 2012 |
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study |
Abstract in rivista |
Vai |
| 2012 |
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. |
Articolo in rivista |
Vai |
| 2012 |
Cloni di carciofo "Romanesco" in coltura annuale in Sicilia |
Articolo in rivista |
Vai |
| 2012 |
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. |
Abstract in rivista |
Vai |
| 2011 |
Improving diagnostic accuracy in Celiac Disease diagnosis: anti-endomysium antibody assay in colture medium of duodenal biopsies. |
Proceedings |
Vai |
| 2011 |
Food hypersensitivity-associated irritable bowel syndrome: may fecal assays improve diagnosis? |
Proceedings |
Vai |
| 2011 |
REPORT OF A CASE OF MALIGNANT TUMOR-LIKE GASTRIC LESION BY CANDIDA IN A DIABETIC TREATED WITH CYCLOSPORINE FOR PSORIASIS AND REVIEW OF THE LITERATURE |
Articolo in rivista |
Vai |
| 2011 |
Lichen sclerosus and atrophicus: report of a case of female patient affected with recurrent cystitis. |
Proceedings |
Vai |
| 2011 |
Osteodystrophy in chronic liver diseases. |
Articolo in rivista |
Vai |
| 2011 |
Malignant tumor-like gastric lesion by Candida albicans. |
Proceedings |
Vai |
| 2011 |
Effects of hypolipidemic and hypoglycemic
agents on atherogenic small, dense LDL in
Type 2 diabetes |
Articolo in rivista |
Vai |
| 2011 |
Rare Candida albicans overgrowth in an immunosuppressed patient: case report of a malignant tumor-like gastric lesion. |
Proceedings |
Vai |
| 2011 |
Prevalence of antibodies anti-bartonella henselae in western Sicily: children, blood donors, cats |
Proceedings |
Vai |
| 2011 |
Improving diagnostic accuracy in celiac disease diagnosis: antiendomysium antibody assay in the culture medium of duodenal biopsies. |
Proceedings |
Vai |
| 2011 |
Food hypersensitivity in patients with irritable bowel syndrome: the diagnostic role of fecal assays. |
Proceedings |
Vai |
| 2011 |
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect |
Articolo in rivista |
Vai |
| 2010 |
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. |
Abstract in rivista |
Vai |
| 2008 |
Diagnostica non invasiva delle varici esofagee nei pazienti con cirrosi epatica: dati ecografici vs dati endoscopici |
Articolo in rivista |
Vai |
| 2007 |
Variazioni emodinamiche del circolo epatico in pazienti con bright liver ecopattern e sindrome metabolica |
Proceedings |
Vai |
| 2006 |
O- Alkylation of a lignite humic acid by phase-transfer catalysis |
Articolo in rivista |
Vai |
| 2004 |
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins |
Articolo in rivista |
Vai |
